“SRI is uniquely positioned to be able to help make healthcare something that is for all, not just for a select few,” said David Motley, Chair of the SRI Board of Directors. Hear more from David as he discusses SRI’s transformative role and legacy in health, AI, climate, and beyond. https://lnkd.in/gVi4krNc #health #healthcare #precisionmedicine
SRI Biosciences
Biotechnology Research
Menlo Park, California 1,037 followers
Developing next-gen drugs, diagnostics, and technologies to solve unmet medical needs and propel innovation to market.
About us
SRI Biosciences—a division of SRI—conducts cutting-edge research, invents new platform technologies to advance biomedical discovery, and delivers next-generation drugs, diagnostics, and devices to solve unmet medical needs. We work with commercial, government, and academic clients and partners to develop transformative approaches and platforms for the toughest therapeutic challenges. Our pioneering research in human sleep, immuno-oncology, drug delivery, point-of-care diagnostics, therapeutic discovery, and more aims to help save and improve lives worldwide.
- Website
-
https://www.sri.com/biomedical-sciences/
External link for SRI Biosciences
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Menlo Park, California
- Specialties
- drug discovery, drug development, formulation development, pharmacology/toxicology, medicinal chemistry, automated chemical synthesis, neuroscience, human sleep research, proteomics, diagnostics, immuno-oncology, targeted drug delivery, intracellular drug delivery, nucleic acid delivery, biological assay development, high-throughput screening, CRISPR, medical imaging, virology, and nonclinical development
Updates
-
SRI scientists are developing a cell-based platform using an often-undervalued subset of helper T cells to deliver potent antitumor proteins for solid tumors, overcoming dose-related toxicities. Learn more and read the recent publication in the Proceedings of the National Academy of Sciences: https://lnkd.in/eDYsQnZW Harikrishnan Radhakrishnan Parijat Bhatnagar, Ph.D. #precisionmedicine #biotech #drugdelivery
-
We'll be at the James Madison University College of Science & Mathematics (CSM) Annual Career Conference next week! Attending the conference? Hear from SRI's Alex Clippinger in the Pharmaceutical Development Industry Panel at 1:45 pm in the Highlands Room in Festival Hall. View the event details: https://lnkd.in/e6ap5Ft9 #pharma #pharmacareers #drugdevelopment
-
Earlier this year, SRI’s TALL (Targeted Antigen Loaded Liposomes) immunotherapy earned FDA orphan drug designation for pancreatic cancer — a designation that accelerates clinical development and brings new and novel therapies to the market faster. Learn more about TALL and the recent orphan drug designation by FDA: https://lnkd.in/e2p-X9va #WorldCancerDay #cancerresearch #pancreaticcancer
-
Did you know teens need more sleep than adults? In addition to needing more hours, they experience a natural body rhythm change that impacts the time they go to bed, shifting more toward "night owl" tendencies. In a recent episode of mindbodygreen.com podcast, SRI’s sleep expert Fiona Baker discusses a range of sleep topics including differences by age and sex, dreaming, impacts on mental health, practices for healthy sleep, and wearable devices for tracking sleep. Listen to the full podcast: https://lnkd.in/gdFn2AjV #backtoschool #sleep #sleephealth
-
Did you know SRI has a Clinical Trials Unit in Plymouth, Michigan that can support Phase 1-4 trials? We have a successful, decade-long track record conducting government and commercial trials from startup to study close in a range of therapeutic areas. We're actively recruiting new PIs to support upcoming trials. For more information, visit our careers site: https://lnkd.in/e85p2dCF #clinicalresearch #clinicaltrials #hiring
-
We’ll be at the Radiation Research Society 2024 Annual Meeting next week! Join us Sunday, September 15th in Poster Session II at poster PS2-02 to learn about our work — supported by National Institute of Allergy and Infectious Diseases (NIAID) — advancing promising medical countermeasures intended to mitigate acute and delayed radiation-induced injuries. James. Bakke J. Tyson McDonald, PhD Tyler Beach Debbie Bunin Denise Nishita Shweta Kapur Janet Gahagen Polly Chang #RadRes2024 #radiationresearch #preclinical
-
SRI researchers are using AI to analyze data to pinpoint obesity risk factors in adolescents. This research was published as one of several peer-reviewed papers as part of SRI’s contribution to the Adolescent Brain Cognitive Development (ABCD) study — a decade-old, U.S.-focused study that has collected data from tens of thousands of participants and is the single largest long-term study of brain development and child health ever undertaken. Learn more about this research and the ABCD study here: https://lnkd.in/gzH2HGQn Orsolya Kiss Fiona Baker Jason Nagata #AI #wearables #sleephealth
-
We’re moving technologies out of the lab to make an impact. Hear from Suresh Sunderrajan, President of Commercialization, as he shares how incredible it is to consider the ways the projects at SRI are making a difference — like discovering a new pathway to treat cancer. https://lnkd.in/gGXu_cfE #precisionmedicine #health #innovation
-
Join us in congratulating Senior Microbiologist Emeritus, Kristien Mortelmans, on receiving the Society for Industrial Microbiology and Biotechnology fellowship award for exceptional dedication. Kristien has made decades of contributions to SRI and the fields of industrial, medical, and environmental microbiology. Learn more about her scientific discoveries, her journey to SRI, and her lifelong fascination with bacteria: https://lnkd.in/ddsje6CJ #microbiology #biotechnology #bacteria